MedTrace Logo

Bispectral Index and Patient State Index During General Anesthesia With Remimazolam

NCT05432050 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-07-01

No results posted yet for this study

Summary

The aim of this study is to compare the bispectral index (BIS) and patient state index (PSI) during general anesthesia using remimazolam. The infusion rate of remimazolam is 6-12mg/kg/h during induction of anesthesia and 1-2mg/kg/h during maintenance of anesthesia. To calculate the fraction, the sum of times when BIS\<60 and PSI \<50 will be divided by the time from the loss of consciousness during induction of anesthesia to fully awake during emergence. We will compare the fraction of BIS \<60 and the fraction of PSI \<50 to find if there is some difference between the two depth of anesthesia monitoring devices during remimazolam anesthesia.

Conditions

  • Remimazolam
  • Anesthesia, General
  • Hypnotics and Sedatives
  • Thyroid Disease
  • Breast Diseases
  • Parathyroid Diseases

Interventions

DEVICE

Bispectral index and Patient state index monitoring

The depth of anesthesia will be monitored with both the bispectral index and patient state index at the same time.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee-Soo Kim, MD,PhD · Professor

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432050 on ClinicalTrials.gov